| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | Chief Financial Officer | Common Stock | 18.7K | $4.57M | $243.92 | Jan 23, 2024 | Direct |
| MADRIGAL PHARMACEUTICALS, INC. | Chief Financial Officer | Market Stock Unit | 4.8K | $1.17M | $243.92 | Jan 23, 2024 | Direct |
| MADRIGAL PHARMACEUTICALS, INC. | Chief Financial Officer | Stock Option (Right to Buy) | 7.24K | Jan 23, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Jan 23, 2024 | 3 | $0 | 4 | Jan 25, 2024 | Chief Financial Officer |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Jan 16, 2024 | 1 | -$260K | 4 | Jan 18, 2024 | Chief Financial Officer |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Jan 16, 2023 | 1 | $0 | 4 | Jan 18, 2023 | Chief Financial Officer |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Feb 22, 2022 | 1 | $0 | 4 | Feb 24, 2022 | Chief Financial Officer |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Nov 1, 2021 | 1 | $0 | 4 | Nov 3, 2021 | Chief Financial Officer |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | May 17, 2021 | 1 | $0 | 4 | May 19, 2021 | Chief Financial Officer |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | May 17, 2021 | 0 | $0 | 3 | May 19, 2021 | Chief Financial Officer |